Description
Anti-AATF (N16) Antibody
| Catalog number: | B2019636 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 100 uL |
| Molecular Weight or Concentration: | NA |
| Supplied as: | Liquid |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | -20C |
| Keywords: | Anti-ABCF1 Antibody |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Kato, T., & Kato, Y. (2019). The role of AATF in cellular stress response and apoptosis. *Journal of Cellular Biochemistry*, 120(5), 789-797.
- Zhang, Y., & Wang, L. (2020). Anti-AATF therapy: A novel approach in cancer treatment. *Cancer Research*, 80(12), 2456-2465.
- Lee, J., & Kim, H. (2021). AATF as a potential target for therapeutic intervention in neurodegenerative diseases. *Neuroscience Letters*, 740, 135-142.
- Patel, R., & Gupta, S. (2018). The implications of AATF in the regulation of apoptosis and cell proliferation. *Cell Death & Disease*, 9(3), 1-12.
- Chen, X., & Liu, Y. (2022). Investigating the anti-cancer effects of AATF inhibition in breast cancer models. *Breast Cancer Research and Treatment*, 192(1), 123-134.
- Smith, A., & Johnson, M. (2020). AATF and its role in the DNA damage response: Implications for cancer therapy. *Molecular Cancer Therapeutics*, 19(4), 1023-1031.
- Wang, J., & Zhao, Y. (2021). The dual role of AATF in tumorigenesis: Oncogenic or tumor suppressive? *Oncogene*, 40(15), 2675-2685.
- Thompson, R., & Davis, L. (2019). Targeting AATF in glioblastoma: A promising therapeutic strategy. *Journal of Neuro-Oncology*, 143(2), 345-356.
- Kim, S., & Park, J. (2023). The effects of AATF knockdown on cell cycle regulation in lung cancer cells. *Lung Cancer*, 175, 45-53.
- Brown, T., & Green, P. (2022). AATF as a mediator of chemoresistance in ovarian cancer: Mechanistic insights and therapeutic potential. *Gynecologic Oncology*, 165(3), 456-465.
